• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

三尖瓣置换手术的长期预后及危险因素:一项单中心研究

Long-term prognosis and risk factors in tricuspid valve replacement surgery: a single-center study.

作者信息

Ke Yingjie, Hua Linbin, Pang Shanwen, Wang Qiuji, Zhong Lishan, Wang Zhenzhong, Zhou Kan, Zeng Rong, Huang Huanlei

机构信息

Department of Cardiovascular Surgery, Guangdong Provincial People's Hospital (Guangdong Academy of Medical Sciences), Southern Medical University, Guangzhou, Guangdong, China.

Department of Cardiovascular Surgery, Guangdong Provincial People's Hospital's Nanhai Hospital, The Second People's Hospital of Nanhai District Foshan City, Foshan, Guangdong, China.

出版信息

Front Surg. 2025 Apr 8;12:1532945. doi: 10.3389/fsurg.2025.1532945. eCollection 2025.

DOI:10.3389/fsurg.2025.1532945
PMID:40264744
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12011789/
Abstract

BACKGROUND

Tricuspid valve replacement (TVR), although accounting for a minority of heart valve surgeries, poses significant challenges, including poor patients' condition, prosthetic complications, and increased perioperative mortality rates. Despite preferences for valvuloplasty, some cases necessitate replacement. The choice of tricuspid valve type remains controversial, and there is no consensus on surgical risk factors. Additionally, long-term follow-up reports on a large number of cases are lacking. In this study, we aimed to analyze the medical records of the largest number of patients who underwent TVR surgery.

METHODS

Patients who underwent TVR between 1999 and 2023 were divided into mechanical (MTVR) and bioprosthetic (BTVR) groups. Risk factors for overall mortality were analyzed.

RESULTS

In total, 626 patients were enrolled. The in-hospital and overall mortality rates were 12.1% and 42.8%, respectively. The in-hospital mortality rate (7.0% vs. 14.2%), incidence of acute renal insufficiency (4.3% vs. 12.2%), and hemodialysis rate (3.2% vs. 10.4%) were significantly higher in the BTVR group than in the MTVR group ( < 0.01). The median follow-up was 11 years (range 0.1-24 years). The MTVR group had significantly higher rates of long-term survival, hemorrhagic events, heart failure events, and re-operation rates than the BTVR group ( < 0.01). Multifactorial logistic regression analysis identified body weight, New York heart function classification, extracorporeal circulation time, and ventilator time as independent risk factors for in-hospital mortality. New York heart function classification during follow-up was identified as an independent risk factor for overall patient mortality.

CONCLUSIONS

MTVR was superior to BTVR regarding short- and long-term outcomes. New York heart function classification was associated with short- and long-term mortality.

摘要

背景

三尖瓣置换术(TVR)虽然在心脏瓣膜手术中占少数,但带来了重大挑战,包括患者病情较差、人工瓣膜并发症以及围手术期死亡率增加。尽管人们更倾向于瓣膜成形术,但某些病例仍需要进行置换。三尖瓣类型的选择仍存在争议,对于手术风险因素也没有共识。此外,缺乏大量病例的长期随访报告。在本研究中,我们旨在分析接受TVR手术的患者数量最多的病历。

方法

将1999年至2023年间接受TVR的患者分为机械瓣膜组(MTVR)和生物瓣膜组(BTVR)。分析总体死亡率的风险因素。

结果

共纳入626例患者。住院死亡率和总体死亡率分别为12.1%和42.8%。BTVR组的住院死亡率(7.0%对14.2%)、急性肾功能不全发生率(4.3%对12.2%)和血液透析率(3.2%对10.4%)显著高于MTVR组(<0.01)。中位随访时间为11年(范围0.1 - 24年)。MTVR组的长期生存率、出血事件、心力衰竭事件和再次手术率显著高于BTVR组(<0.01)。多因素逻辑回归分析确定体重、纽约心脏功能分级、体外循环时间和呼吸机使用时间为住院死亡率的独立风险因素。随访期间的纽约心脏功能分级被确定为患者总体死亡率的独立风险因素。

结论

在短期和长期结果方面,MTVR优于BTVR。纽约心脏功能分级与短期和长期死亡率相关。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6527/12011789/0985e9710f65/fsurg-12-1532945-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6527/12011789/12f3b2e84a26/fsurg-12-1532945-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6527/12011789/0985e9710f65/fsurg-12-1532945-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6527/12011789/12f3b2e84a26/fsurg-12-1532945-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6527/12011789/0985e9710f65/fsurg-12-1532945-g002.jpg

相似文献

1
Long-term prognosis and risk factors in tricuspid valve replacement surgery: a single-center study.三尖瓣置换手术的长期预后及危险因素:一项单中心研究
Front Surg. 2025 Apr 8;12:1532945. doi: 10.3389/fsurg.2025.1532945. eCollection 2025.
2
Comparative analysis of structural valve deterioration after bioprosthetic tricuspid valve replacement: Bovine pericardial versus porcine valves.生物瓣三尖瓣置换术后结构性瓣膜衰败的对比分析:牛心包与猪瓣。
Artif Organs. 2021 Aug;45(8):911-918. doi: 10.1111/aor.13909. Epub 2021 Mar 4.
3
Reappraisal of mechanical tricuspid valve replacement in the current era: a single center retrospective study.当前时代机械三尖瓣置换术的重新评估:一项单中心回顾性研究
J Thorac Dis. 2021 Jun;13(6):3359-3368. doi: 10.21037/jtd-20-3027.
4
Tricuspid valve replacement: the effect of gender on operative results.三尖瓣置换术:性别对手术结果的影响。
J Heart Valve Dis. 2014 Mar;23(2):209-15.
5
Results and factors associated with adverse outcome after tricuspid valve replacement.三尖瓣置换术后不良结局的结果和相关因素。
Kardiol Pol. 2018;76(4):731-739. doi: 10.5603/KP.a2018.0026. Epub 2018 Mar 28.
6
Outcomes of Ebstein's Anomaly Patients Treated with Tricuspid Valvuloplasty or Tricuspid Valve Replacement: Experience of a Single Center.三尖瓣成形术或置换术治疗Ebstein 畸形患者的结局:单中心经验。
Chin Med J (Engl). 2018 May 5;131(9):1067-1074. doi: 10.4103/0366-6999.230731.
7
Which type of valve should we use in tricuspid position? Long-term comparison between mechanical and biological valves.我们应该在三尖瓣位置使用哪种类型的瓣膜?机械瓣膜和生物瓣膜的长期比较。
J Cardiovasc Surg (Torino). 2017 Oct;58(5):739-746. doi: 10.23736/S0021-9509.16.09553-7. Epub 2016 Sep 16.
8
Fifteen-Year Outcomes After Bioprosthetic and Mechanical Tricuspid Valve Replacement.三尖瓣生物瓣和机械瓣置换术后 15 年的结果。
Ann Thorac Surg. 2020 Nov;110(5):1564-1571. doi: 10.1016/j.athoracsur.2020.02.040. Epub 2020 Mar 26.
9
Long-term outcomes of tricuspid valve replacement after previous left-side heart surgery.既往左侧心脏手术后三尖瓣置换术的长期预后
Eur J Cardiothorac Surg. 2014 Oct;46(4):713-9; discussion 719. doi: 10.1093/ejcts/ezt638. Epub 2014 Jan 28.
10
Comparison of valvuloplasty and replacement for surgical treatment of tricuspid infective endocarditis.比较成形术和置换术在三尖瓣感染性心内膜炎外科治疗中的应用。
BMC Cardiovasc Disord. 2023 Apr 28;23(1):213. doi: 10.1186/s12872-023-03248-1.

本文引用的文献

1
Long-Term Outcomes of Tricuspid Valve Replacement With Mechanical Versus Tissue Valves: Meta-Analysis of Reconstructed Time-to-Event Data.三尖瓣置换术后机械瓣与生物瓣的长期结局:重建时间事件数据的荟萃分析。
Am J Cardiol. 2024 Aug 15;225:89-97. doi: 10.1016/j.amjcard.2024.06.010. Epub 2024 Jun 17.
2
Tricuspid valve replacement provides better long-term survival and tricuspid valve function than repair in patients with systemic right ventricle.对于右心室功能不全的患者,三尖瓣置换术比三尖瓣修复术能提供更好的长期生存率和三尖瓣功能。
JTCVS Open. 2023 Jul 6;15:382-393. doi: 10.1016/j.xjon.2023.06.013. eCollection 2023 Sep.
3
Long-Term Outcomes of Bioprosthetic and Mechanical Tricuspid Valve Replacement after Left-Sided Valves Surgery.
二尖瓣手术后生物瓣和机械三尖瓣置换的长期结果。
Ann Thorac Cardiovasc Surg. 2023 Dec 20;29(6):307-314. doi: 10.5761/atcs.oa.23-00041. Epub 2023 Jun 29.
4
Five-year outcomes of tricuspid valve repair versus replacement; a propensity score-matched analysis.三尖瓣修复与置换的 5 年结果:倾向评分匹配分析。
Asian Cardiovasc Thorac Ann. 2023 Jun;31(5):413-420. doi: 10.1177/02184923231176508. Epub 2023 May 16.
5
Isolated Tricuspid Valve Repair Versus Replacement: Predictors of Mortality on the National Level.孤立性三尖瓣修复与置换:全国水平的死亡率预测因素。
Innovations (Phila). 2023 Jan-Feb;18(1):58-66. doi: 10.1177/15569845231153127. Epub 2023 Feb 20.
6
Outcomes of isolated tricuspid valve replacement: a systematic review and meta-analysis of 5,316 patients from 35 studies.孤立性三尖瓣置换术的结局:35 项研究中 5316 例患者的系统评价和荟萃分析。
EuroIntervention. 2022 Nov 18;18(10):840-851. doi: 10.4244/EIJ-D-22-00442.
7
Tricuspid valve replacement: The old and the new.三尖瓣置换术:旧与新。
Prog Cardiovasc Dis. 2022 May-Jun;72:102-113. doi: 10.1016/j.pcad.2022.06.004. Epub 2022 Jun 20.
8
Isolated Tricuspid Valve Replacement for Infective Endocarditis.感染性心内膜炎的孤立性三尖瓣置换术
Cardiol Res. 2022 Apr;13(2):110-117. doi: 10.14740/cr1359. Epub 2022 Mar 12.
9
Tricuspid valve regurgitation: current diagnosis and treatment.三尖瓣反流:当前的诊断与治疗
Am J Cardiovasc Dis. 2022 Feb 15;12(1):1-18. eCollection 2022.
10
The Mid-Term Outcomes of Cone Repair or Replacement of Tricuspid Valve in Patients with Ebstein's Anomaly: Our Experience.Ebstein 畸形患者行三尖瓣圆锥修复或置换的中期结果:我们的经验。
Heart Surg Forum. 2022 Jan 17;25(1):E030-E036. doi: 10.1532/hsf.4165.